|
MechanismPI3Kδ inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date24 Mar 2023 |
100 Clinical Results associated with Ballia Holdings Pty. Ltd.
0 Patents (Medical) associated with Ballia Holdings Pty. Ltd.
100 Deals associated with Ballia Holdings Pty. Ltd.
100 Translational Medicine associated with Ballia Holdings Pty. Ltd.